Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

NCT02217475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: Cenicriviroc
DRUG: Placebo

Sponsor

Tobira Therapeutics, Inc.